Merit Medical (NSDQ:MMSI) said today that it paid $97.5 million in cash to acquire DFine and created a new division to incorporate DFine’s spine devices. San Jose, Calif.-based DFine makes the StabiliT line of devices, for injecting bone cement into vertebral fractures, and the Star spine tumor ablation system. Jordan, Utah-based Merit said its new interventional oncology […]
DFine launches tumor ‘melting’ trial
Spinal therapies maker DFine Inc. launched enrollment in a clinical trial of its STAR tumor ablation system, evaluating the technology in treatment of spinal tumors.
The new EU-STAR clinical trial will enroll 40 patients at 5 centers in Germany and France, DFine reported. Researchers are looking to examine patients’ pain from 1 month following the procedure out to 6 months, as well as patients’ function, quality of life and reliance on pain medications.
Imaging3 loses director, president & COO Sohn | Personnel Moves
Imaging3 (OTC:IMGG) president & COO resigned "to pursue other interests," according to a regulatory filing, leaving the mobile fluoroscopy device maker without a replacement.
Sohn, whose resignation was effective March 31, was still listed on Imaging3’s website today. The company agreed to pay out $9,100 in severance, according to the filing.